Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Liang, Chao  [Clear All Filters]
2015
Zhou Y, Liang C, Xue F, Chen W, Zhi X, Feng X, Bai X, Liang T. Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation. Oncotarget. 2015.
2016
Wei Z-R, Liang C, Feng D, Cheng Y-J, Wang W-M, Yang D-J, Wang Y-X, Cai Q-P. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer. Oncotarget. 2016.
2021
Wang L, Liang C, Lin X, Liu C, Li J. microRNA-491-5p regulates osteogenic differentiation of bone marrow stem cells in type 2 diabetes. Oral Dis. 2021.
2022
Liang Q, Liang C, Liu X, Xing X, Ma S, Huang H, Liang C, Liu L, Liao L, Tian W. Vascularized dental pulp regeneration using cell-laden microfiber aggregates. J Mater Chem B. 2022.
Kang X, Chen L, Yang S, Gong Z, Hu HY, Zhang X, Liang C, Xu Y. Zuogui Wan slowed senescence of bone marrow mesenchymal stem cells by suppressing Wnt/β-catenin signaling. J Ethnopharmacol. 2022:115323.
2024
Wang Y, Sun Y, Yang B, Li J, Liang C. The effect and mechanism of liraglutide on the biological functions of BMSCs in diabetic patients. Oral Dis. 2024.
Tian D, You X, Ye J, Chen G, Yu H, Lv J, Shan F, Liang C, Bi Y, Jing J, et al. hBcl2 overexpression in BMSCs enhances resistance to myelin debris-induced apoptosis and facilitates neuroprotection after spinal cord injury in rats. Sci Rep. 2024;14(1):1830.